» Articles » PMID: 35330187

Effect of Dietary Polyphenols on Osteoarthritis-Molecular Mechanisms

Overview
Journal Life (Basel)
Specialty Biology
Date 2022 Mar 25
PMID 35330187
Authors
Affiliations
Soon will be listed here.
Abstract

Osteoarthritis is a common crippling and degenerative disease resulting in irreversible functional changes due to damage of the cartilage and other tissues of the joint. With limited safe and effective pharmaceutical treatments, the demand and use for alternative therapeutic approaches with symptomatic relief for OA patients have increased. Clinical, pre-clinical, and in vitro studies have demonstrated that polyphenols can exert pain-relieving symptoms coupled with increased functional capacity in OA models. This review will highlight studies carried out in the last five years to define the efficacies and underlying mechanisms in polyphenols such as quercetin, resveratrol, curcumin, epigallocatechin-3-gallate, rosmarinic acid, genistein, ginger, berries, silver fir, pine bark, and . Most of these studies indicate that polyphenols exhibit their beneficial roles through regulating changes at the biochemical and molecular levels, inducing or inhibiting various signaling pathways related to inflammation and oxidative stress. Polyphenols have also been implicated in modulating microRNA at the posttranscriptional level to counteract OA pathogenesis.

Citing Articles

Root Extract Attenuates Osteoarthritis Progression by Inhibiting Inflammation and Cartilage Degradation in Interleukin-1β and Monosodium Iodoacetate-Induced Osteoarthritis Models.

Park Y, Shin D, Lee H, Hwang H, Kim J, Kim B Nutrients. 2024; 16(22).

PMID: 39599668 PMC: 11597245. DOI: 10.3390/nu16223882.


Advances in Gouty Arthritis Management: Integration of Established Therapies, Emerging Treatments, and Lifestyle Interventions.

Yao T, Lee R, Wu W, Chen I, Yu T, Yeh K Int J Mol Sci. 2024; 25(19).

PMID: 39409183 PMC: 11477016. DOI: 10.3390/ijms251910853.


Nutritional Strategies for Chronic Craniofacial Pain and Temporomandibular Disorders: Current Clinical and Preclinical Insights.

Piriyaprasath K, Kakihara Y, Hasegawa M, Iwamoto Y, Hasegawa Y, Fujii N Nutrients. 2024; 16(17).

PMID: 39275184 PMC: 11397166. DOI: 10.3390/nu16172868.


Harnessing the Power of Polyphenols: A New Frontier in Disease Prevention and Therapy.

El Oirdi M Pharmaceuticals (Basel). 2024; 17(6).

PMID: 38931359 PMC: 11206774. DOI: 10.3390/ph17060692.


Evaluating the Anti-Osteoarthritis Potential of Standardized Gum Resin Extract in Alleviating Knee Joint Pathology and Inflammation in Osteoarthritis-Induced Models.

Choi Y, Jung J, Bae J, Lee J, Kim E Int J Mol Sci. 2024; 25(6).

PMID: 38542192 PMC: 10970542. DOI: 10.3390/ijms25063218.


References
1.
Chang L, Yao H, Yao Z, Ho K, Ong M, Dai B . Comprehensive Analysis of Key Genes, Signaling Pathways and miRNAs in Human Knee Osteoarthritis: Based on Bioinformatics. Front Pharmacol. 2021; 12:730587. PMC: 8419250. DOI: 10.3389/fphar.2021.730587. View

2.
Ito Y, Matsuzaki T, Ayabe F, Mokuda S, Kurimoto R, Matsushima T . Both microRNA-455-5p and -3p repress hypoxia-inducible factor-2α expression and coordinately regulate cartilage homeostasis. Nat Commun. 2021; 12(1):4148. PMC: 8260725. DOI: 10.1038/s41467-021-24460-7. View

3.
Xu X, Liu X, Yang Y, He J, Jiang M, Huang Y . Resveratrol Exerts Anti-Osteoarthritic Effect by Inhibiting TLR4/NF-κB Signaling Pathway via the TLR4/Akt/FoxO1 Axis in IL-1β-Stimulated SW1353 Cells. Drug Des Devel Ther. 2020; 14:2079-2090. PMC: 7274521. DOI: 10.2147/DDDT.S244059. View

4.
Nakagawa Y, Mukai S, Yamada S, Murata S, Yabumoto H, Maeda T . The Efficacy and Safety of Highly-Bioavailable Curcumin for Treating Knee Osteoarthritis: A 6-Month Open-Labeled Prospective Study. Clin Med Insights Arthritis Musculoskelet Disord. 2020; 13:1179544120948471. PMC: 7425263. DOI: 10.1177/1179544120948471. View

5.
Jessberger S, Hogger P, Genest F, Salter D, Seefried L . Cellular pharmacodynamic effects of Pycnogenol® in patients with severe osteoarthritis: a randomized controlled pilot study. BMC Complement Altern Med. 2017; 17(1):537. PMC: 5732384. DOI: 10.1186/s12906-017-2044-1. View